Published in N Engl J Med on February 12, 1998
British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax (2003) 5.83
Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Fam Med (2007) 1.54
Metastatic involvement of a retrieved inferior vena cava filter. J Vasc Interv Radiol (2003) 1.49
Diagnosis and treatment of deep-vein thrombosis. CMAJ (2006) 1.44
Vena Caval Filter Utilization and Outcomes in Pulmonary Embolism: Medicare Hospitalizations From 1999 to 2010. J Am Coll Cardiol (2016) 1.43
Retracted Use of Prophylactic Inferior Vena Cava Filters in Trauma. Sultan Qaboos Univ Med J (2016) 1.39
High prevalence of iliofemoral venous thrombosis with severe groin infection among injecting drug users in North East Scotland: successful use of low molecular weight heparin with antibiotics. Postgrad Med J (2000) 1.23
CT pulmonary angiography after total joint arthroplasty: overdiagnosis and iatrogenic harm? Clin Orthop Relat Res (2013) 1.23
The need for randomization in animal trials: an overview of systematic reviews. PLoS One (2014) 1.22
Inferior vena cava filters. Semin Intervent Radiol (2006) 1.21
Deep vein thrombosis: a clinical review. J Blood Med (2011) 1.15
Complications of inferior vena caval filters. Semin Intervent Radiol (2006) 1.14
Inferior vena cava filtration in the management of venous thromboembolism: filtering the data. Semin Intervent Radiol (2012) 1.07
A population-based study of inferior vena cava filters in patients with acute venous thromboembolism. Arch Intern Med (2010) 1.04
Management of submassive pulmonary embolism. Circulation (2010) 1.03
Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients. J Gen Intern Med (2010) 1.00
Inferior vena cava filters for recurrent thrombosis: current evidence. Tex Heart Inst J (2007) 0.96
Cancer-associated thrombosis: prevention and treatment. Curr Oncol (2008) 0.95
Symptomatic caval penetration by a Celect inferior vena cava filter. Pediatr Radiol (2009) 0.94
Medical management of brain tumors and the sequelae of treatment. Neuro Oncol (2014) 0.94
Retrospective analysis of the use of inferior vena cava filters in routine hospital practice. Postgrad Med J (2006) 0.93
Management dilemmas in acute pulmonary embolism. Thorax (2013) 0.93
Venous thromboembolic disease. J Natl Compr Canc Netw (2011) 0.93
Improving the tracking and removal of retrievable inferior vena cava filters. Semin Intervent Radiol (2011) 0.92
Deep Venous Thrombosis and Pulmonary Embolism. Curr Treat Options Cardiovasc Med (2002) 0.90
Pharmacologic venous thromboembolism prophylaxis after traumatic brain injury: a critical literature review. J Neurotrauma (2012) 0.88
Inferior vena cava filters for primary prophylaxis: when are they indicated? Semin Intervent Radiol (2012) 0.88
Endovascular treatment for iliac vein compression syndrome: a comparison between the presence and absence of secondary thrombosis. Korean J Radiol (2009) 0.87
Benefit vs. Risk of a Permanent Inferior Vena Cava Filter in Pulmonary Embolism with Anticoagulation Contraindication. Maedica (Buchar) (2013) 0.86
Hemorrhagic shock with delayed retroperitoneal hemorrhage after deployment of an inferior vena cava filter: report of a case. Surg Today (2007) 0.84
Management of massive and nonmassive pulmonary embolism. Arch Med Sci (2012) 0.84
Optional inferior vena caval filters: where are we now? Eur Radiol (2008) 0.83
Diagnosis and treatment of deep-vein thrombosis and approach to venous thromboembolism in obstetrics and gynecology. J Turk Ger Gynecol Assoc (2011) 0.83
Open pulmonary thromboembolectomy in patients with major pulmonary thromboembolism. Yonsei Med J (2008) 0.83
Inferior vena cava filters in cancer patients: to filter or not to filter. Ther Clin Risk Manag (2011) 0.83
Clinical outcome of perioperative nonpermanent vena cava filter placement in patients with deep venous thrombosis or blood stasis of the vein. Surg Today (2009) 0.82
Cost-effectiveness of low-molecular-weight heparin in the treatment of proximal deep vein thrombosis. J Gen Intern Med (2000) 0.82
Retrievable inferior vena cava filters may be safely applied in gastric bypass surgery. Surg Endosc (2007) 0.81
Bleeding risk during treatment of acute thrombotic events with subcutaneous LMWH compared to intravenous unfractionated heparin; a systematic review. PLoS One (2012) 0.81
Vena caval filters for the prevention of pulmonary embolism. N Engl J Med (1998) 0.81
High incidence of complications from enoxaparin treatment after arthroplasty. Clin Orthop Relat Res (2009) 0.81
Pulmonary embolism after IVC filter. HSS J (2007) 0.81
Optional inferior vena cava filters in the trauma patient. Semin Intervent Radiol (2010) 0.81
Recent advances in the management of pulmonary embolism: focus on the critically ill patients. Ann Intensive Care (2016) 0.81
Retrievable inferior vena cava filters for venous thromboembolism. ISRN Radiol (2013) 0.80
Symptomatic inferior vena cava perforation by a retrievable filter: Report of two cases and a literature review. Int J Angiol (2009) 0.80
An economic evaluation of venous thromboembolism prophylaxis strategies in critically ill trauma patients at risk of bleeding. PLoS Med (2009) 0.80
Procedural and indwelling complications with inferior vena cava filters: frequency, etiology, and management. Semin Intervent Radiol (2015) 0.80
Cancer and coagulation. Am J Hematol (2012) 0.80
The use of paired optionally retrievable günther tulip filters in trauma patients with anatomical variants. Semin Intervent Radiol (2007) 0.80
Investigating the benefit of adding a vena cava filter to anticoagulation with fondaparinux sodium in patients with cancer and venous thromboembolism in a prospective randomized clinical trial. Support Care Cancer (2012) 0.80
Venous thromboembolism risk factors in Chinese non-small cell lung cancer patients. Support Care Cancer (2014) 0.80
Retrievable inferior vena cava filters can be placed and removed with a high degree of success: Initial experience. Catheter Cardiovasc Interv (2015) 0.79
Do inferior vena cava filters reduce the risk of acute pulmonary embolism in preoperative patients with venous thromboembolism? Surg Today (2010) 0.79
Thromboembolism. BMJ Clin Evid (2011) 0.79
Endovascular Interventions for Acute and Chronic Lower Extremity Deep Venous Disease: State of the Art. Radiology (2015) 0.78
Cost-effectiveness of the bird's nest filter for preventing pulmonary embolism among patients with malignant brain tumors and deep venous thrombosis of the lower extremities. Support Care Cancer (2003) 0.78
Preferences in traumatic intracranial hemorrhage: bleeding vs. clotting. Crit Care (2010) 0.78
Iatrogenic percutaneous vascular injuries: clinical presentation, imaging, and management. Semin Intervent Radiol (2015) 0.78
Management of venous thromboembolism: an update. Thromb J (2016) 0.78
Indications, applications, and outcomes of inferior vena cava filters for venous thromboembolism in Japanese patients. Heart Vessels (2015) 0.77
Treating venous thromboembolism in patients with cancer. Expert Rev Hematol (2012) 0.77
Diagnosis and management of iliofemoral deep vein thrombosis: clinical practice guideline. CMAJ (2015) 0.77
Prophylactic Implantation of Inferior Vena Cava Filter during Endovascular Therapies for Deep Venous Thrombosis of the Lower Extremities. Ann Vasc Dis (2011) 0.77
Venous thromboembolism after removal of retrievable inferior vena cava filters. Cardiovasc Intervent Radiol (2009) 0.77
A fractured inferior vena cava filter strut migrating to the left pulmonary artery. Respir Med Case Rep (2015) 0.76
Advances in the diagnosis and treatment of acute pulmonary embolism. F1000 Med Rep (2012) 0.76
The Impact of Cancer on the Clinical Outcome of Patients After Inferior Vena Cava Filter Placement: A Retrospective Cohort Study. Am J Clin Oncol (2016) 0.76
Complications related to deep venous thrombosis prophylaxis in trauma: a systematic review of the literature. J Trauma Manag Outcomes (2010) 0.76
Temporary inferior vena cava filter for deep vein thrombosis and acute pulmonary thromboembolism: effectiveness and indication. Heart Vessels (2006) 0.75
Patient with a massive idiopathic thrombosis in the inferior vena cava. Ann Vasc Dis (2012) 0.75
Successful removal of a Gunther tulip vena cava filter with wall-embedded hook and migration during a retrieval attempt. Acta Radiol Short Rep (2013) 0.75
Vena caval filters for the prevention of pulmonary embolism. N Engl J Med (1998) 0.75
Endovascular treatment of thrombosed inferior vena cava filters: Techniques and short-term outcomes. Indian J Radiol Imaging (2015) 0.75
Methods and Guidelines for Venous Thromboembolism Prevention in Polytrauma Patients with Pelvic and Acetabular Fractures. Open Orthop J (2015) 0.75
Oral anticoagulant therapy in patients receiving haemodialysis: is it time to abandon it? ScientificWorldJournal (2013) 0.75
Three-year experience of prophylactic placement of inferior vena cava filters in women with gynecological cancer. Int J Gen Med (2013) 0.75
Optimal duration of anticoagulation in patients with venous thromboembolism. Indian J Med Res (2011) 0.75
A woman with a maple leaf in her abdomen. CMAJ (2004) 0.75
Recent changes: pulmonary medicine. BMJ (1999) 0.75
Recurrent fracture of a recovery inferior vena cava filter with pulmonary migration. Yale J Biol Med (2012) 0.75
Current Status of the Retrieval Rate of Retrievable Vena Cava Filters in a Tertiary Referral Center in Korea. Vasc Specialist Int (2014) 0.75
Training on insertion and retrieval of optional inferior vena cava filters for interventional radiologists with little or just some experience with the combined use of blood vessel and animal models. Springerplus (2013) 0.75
Should we look for silent pulmonary embolism in patients with deep venous thrombosis? BMC Cardiovasc Disord (2014) 0.75
The use of retrievable inferior vena cava filters in the trauma population. Int J Angiol (2008) 0.75
Inferior vena cava filter thrombosis. Clin Case Rep (2015) 0.75
Caval filters in intensive care: a retrospective study. Drug Des Devel Ther (2014) 0.75
Balloon-trapped Technique for Successful OptEaseFilter Retrieval. Ann Vasc Dis (2011) 0.75
Internal jugular and common femoral venous access for the removal of a long-term embedded vena cava filter. Diagn Interv Radiol (2014) 0.75
The treatment of deep vein thrombosis in the pelvis and leg. Dtsch Arztebl Int (2008) 0.75
Percutaneous options for acute deep vein thrombosis. Semin Intervent Radiol (2005) 0.75
Outcomes of retrievable inferior vena cava filters in patients with deep vein thrombosis and transient contraindication for anticoagulation. Ann Surg Treat Res (2015) 0.75
Venous Thromboembolism in Cancer: An Update of Treatment and Prevention in the Era of Newer Anticoagulants. Front Cardiovasc Med (2016) 0.75
Removal of a Günther Tulip retrievable inferior vena cava filter after 147 days in a pediatric patient. Pediatr Radiol (2006) 0.75
Catheter-Directed Thrombolysis via Small Saphenous Veins for Treating Acute Deep Venous Thrombosis. Med Sci Monit (2016) 0.75
Retrieval of gunther tulip vena cava filter with thrombosed hook and a leg incorporated into the vena cava wall. Ann Vasc Dis (2009) 0.75
Vena cava thrombosis after vena cava filter placement: Incidence and risk factors. J Geriatr Cardiol (2011) 0.75
Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. N Engl J Med (1996) 11.76
Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med (1995) 6.97
Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study. Lancet (2001) 6.88
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med (1999) 6.88
Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J (2009) 6.64
Epidural corticosteroid injections for sciatica due to herniated nucleus pulposus. N Engl J Med (1997) 5.17
Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial. Lancet (2008) 5.01
Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg (1997) 4.47
Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group. N Engl J Med (1996) 4.10
Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg (2001) 3.67
Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med (2001) 3.29
Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Eur Respir J (2010) 2.90
Survival with first-line bosentan in patients with primary pulmonary hypertension. Eur Respir J (2005) 2.83
Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med (1995) 2.76
New oral antithrombotics: a need for laboratory monitoring. For. J Thromb Haemost (2010) 2.73
Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study. Circulation (2008) 2.67
Free-floating thrombus and embolic risk in patients with angiographically confirmed proximal deep venous thrombosis. A prospective study. Arch Intern Med (1997) 2.63
Cortical feedback improves discrimination between figure and background by V1, V2 and V3 neurons. Nature (1998) 2.61
Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest (2001) 2.59
Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. J Vasc Surg (2010) 2.52
Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J (2009) 2.41
Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil. Eur Respir J (2006) 2.39
Cancer resection on the residual lung after pneumonectomy for bronchogenic carcinoma. Ann Thorac Surg (1996) 2.34
EasyMA: a program for the meta-analysis of clinical trials. Comput Methods Programs Biomed (1997) 2.26
Prevention of venous thromboembolism in orthopedic surgery with vitamin K antagonists: a meta-analysis. J Thromb Haemost (2004) 2.25
Systematic lung scans reveal a high frequency of silent pulmonary embolism in patients with proximal deep venous thrombosis. Arch Intern Med (2000) 2.25
Total vertebrectomy for en bloc resection of lung cancer invading the spine. Ann Thorac Surg (1996) 2.14
Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension. Eur Respir J (1998) 2.14
Evaluation of risk factors for laryngeal edema after tracheal extubation in adults and its prevention by dexamethasone. A placebo-controlled, double-blind, multicenter study. Anesthesiology (1992) 2.04
Diagnosis of central venous catheter-related sepsis. Critical level of quantitative tip cultures. Arch Intern Med (1987) 2.03
Splenectomy and chronic thromboembolic pulmonary hypertension. Thorax (2005) 2.03
Primary pulmonary hypertension and fenfluramine use. Br Heart J (1993) 2.02
A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire. N Engl J Med (1997) 1.97
Increased plasma serotonin in primary pulmonary hypertension. Am J Med (1995) 1.86
Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: a European multicenter double-blind trial. The European Cooperative Study Group for Pulmonary Embolism. J Am Coll Cardiol (1992) 1.85
Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension. Eur Respir J (2009) 1.85
Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension. Eur Respir J (2006) 1.78
Does bicarbonate therapy improve the management of severe diabetic ketoacidosis? Crit Care Med (1999) 1.78
A randomized study comparing the efficacy and safety of nadroparin 2850 IU (0.3 mL) vs. enoxaparin 4000 IU (40 mg) in the prevention of venous thromboembolism after colorectal surgery for cancer. J Thromb Haemost (2006) 1.78
Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies. Kidney Int (2006) 1.74
[Guidelines for the diagnosis and treatment of pulmonary hypertension]. Rev Mal Respir (2010) 1.74
Chronic thromboembolic pulmonary hypertension. Eur Respir J (2004) 1.74
Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2. Eur Respir J (2004) 1.73
Feedback connections act on the early part of the responses in monkey visual cortex. J Neurophysiol (2001) 1.71
High prevalence of detectable deep venous thrombosis in patients with acute pulmonary embolism. Chest (1999) 1.70
Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension. Nat Med (2002) 1.65
Pulmonary artery pulse pressure and wave reflection in chronic pulmonary thromboembolism and primary pulmonary hypertension. J Am Coll Cardiol (2001) 1.65
Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial. Circulation (2001) 1.64
Randomized, double-blind study comparing saruplase with streptokinase therapy in acute myocardial infarction: the COMPASS Equivalence Trial. Comparison Trial of Saruplase and Streptokinase (COMASS) Investigators. J Am Coll Cardiol (1998) 1.64
The cytokinesis gene KEULE encodes a Sec1 protein that binds the syntaxin KNOLLE. J Cell Biol (2001) 1.60
The use of combination therapy in pulmonary arterial hypertension: new developments. Eur Respir Rev (2009) 1.60
Double-blind randomised trial of intravenous tissue-type plasminogen activator versus placebo in acute myocardial infarction. Lancet (1985) 1.60
Thrombolysis or heparin therapy in massive pulmonary embolism with right ventricular dilation: results from a 128-patient monocenter registry. Chest (2001) 1.59
Intracoronary stenting without coumadin: one month results of a French multicenter study. Cathet Cardiovasc Diagn (1995) 1.59
Acute hemodynamic interaction of aspirin and ticlopidine with enalapril: results of a double-blind, randomized comparative trial. Circulation (1998) 1.58
Thrombotic thrombocytopenic purpura related to ticlopidine. Lancet (1991) 1.58
Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis. Arch Intern Med (1993) 1.57
Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomised clinical trials. Thromb Haemost (2000) 1.56
Surgical treatment of hepatic and pulmonary metastases from colorectal cancers. Ann Thorac Surg (1998) 1.54
Thrombotic risk factors in pulmonary hypertension. Eur Respir J (2000) 1.54
Double lung transplantation in situs inversus with Kartagener's syndrome. Paris-Sud University Lung Transplant Group. J Thorac Cardiovasc Surg (1994) 1.53
Effects of pentoxifylline on circulating cytokine concentrations and hemodynamics in patients with septic shock: results from a double-blind, randomized, placebo-controlled study. Crit Care Med (1996) 1.52
Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases. Eur Respir J (2007) 1.51
Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. The Association of Non-University Affiliated Intensive Care Specialist Physicians of France. Am J Respir Crit Care Med (2000) 1.51
Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients. Eur Respir J (1998) 1.51
High levels of tumor necrosis factor-alpha and interleukin-6 in the ascitic fluid of cirrhotic patients with spontaneous bacterial peritonitis. Clin Infect Dis (1993) 1.51
Diagnosis and management of subsegmental pulmonary embolism. J Thromb Haemost (2006) 1.47
Risk stratification after myocardial infarction. A reappraisal in the era of thrombolysis. The Groupe d'Etude du Pronostic de l'Infarctus du Myocarde (GREPI) Eur Heart J (1997) 1.47
Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin. Am J Respir Crit Care Med (1995) 1.46
[Risk factors management in 5708 ambulatory patients suffering from peripheral vascular disease followed in urban practices]. Arch Mal Coeur Vaiss (2005) 1.45
Modelling response time profiles in the absence of drug concentrations: definition and performance evaluation of the K-PD model. J Pharmacokinet Pharmacodyn (2006) 1.45
Pulmonary vascular disorders in portal hypertension. Eur Respir J (1998) 1.44
Characterizing patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trial. AIDS (1998) 1.42
Superficial thrombophlebitis of the legs: still a lot to learn. J Thromb Haemost (2005) 1.41
Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertension. Thorax (2004) 1.40
[Lung transplantation]. Presse Med (1989) 1.39
Fatal rupture of pulmonary arteriovenous malformation in hereditary haemorrhagic telangiectasis and severe PAH. Eur Respir Rev (2009) 1.39
Management of severe pulmonary arterial hypertension. Eur Respir Rev (2010) 1.38
Increased morning incidence of myocardial infarction in the ISAM Study: absence with prior beta-adrenergic blockade. ISAM Study Group. Circulation (1989) 1.38
Ventricular fibrillation following administration of thrombolytic treatment. The EMIP experience. European Myocardial Infarction Project. Eur Heart J (1996) 1.38
[Thrombotic thrombocytopenic purpura disclosing cancer: apropos of 2 cases]. Presse Med (1995) 1.38
[Vena cava filters: risks and advantages]. Ann Fr Anesth Reanim (2003) 1.38
Hemodynamic effects of bolus vs 2-h infusion of alteplase in acute massive pulmonary embolism. A randomized controlled multicenter trial. Chest (1994) 1.38